BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30627462)

  • 1. A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy.
    Yamada K; Chigusa Y; Nomura M; Sakanaka K; Nakamura M; Yano S; Tsunoda S; Kondoh E; Mandai M
    Case Rep Obstet Gynecol; 2018; 2018():1280582. PubMed ID: 30627462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
    Algan O; Coia LR; Keller SM; Engstrom PF; Weiner LM; Schultheiss TE; Hanks GE
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):753-61. PubMed ID: 7790262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.
    Swisher SG; Moughan J; Komaki RU; Ajani JA; Wu TT; Hofstetter WL; Konski AA; Willett CG
    J Thorac Oncol; 2017 Feb; 12(2):368-374. PubMed ID: 27729298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Local Recurrence of Esophageal Cancer after Chemoradiation Therapy Successfully Treated with Nivolumab].
    Mizutani M; Segami K; Shimizu K; Sahara K; Kamiya M; Araki K; Miyake M; Shirai J; Tsuchida K; Yoshida T; Ueda M; Mushiake H; Hasegawa S; Fukushima T; Rino Y
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1444-1446. PubMed ID: 38303302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a phase I report.
    Goldberg M; Farma J; Lampert C; Colarusso P; Coia L; Frucht H; Goosenberg E; Beard M; Weiner LM
    J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1168-73. PubMed ID: 14566264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
    Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
    Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
    Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
    Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy: A case report.
    Hirose W; Taniyama Y; Fujishima F; Sato C; Unno M; Kamei T
    Int J Surg Case Rep; 2021 Mar; 80():105617. PubMed ID: 33592421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.
    Lee JL; Park SI; Kim SB; Jung HY; Lee GH; Kim JH; Song HY; Cho KJ; Kim WK; Lee JS; Kim SH; Min YI
    Ann Oncol; 2004 Jun; 15(6):947-54. PubMed ID: 15151953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer].
    Lin Q; Gao XS; Qiao XY; Chen K; Wang YD; Zhou ZG
    Ai Zheng; 2008 Oct; 27(10):1077-81. PubMed ID: 18851788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.
    Ishikawa Y; Suzuki M; Yamaguchi H; Seto I; Machida M; Takagawa Y; Jingu K; Kikuchi Y; Murakami M
    J Med Case Rep; 2022 Feb; 16(1):68. PubMed ID: 35152904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative chemoradiation therapy with 5-fluorouracil and low-dose daily cisplatin for esophageal cancer: a preliminary report.
    Shimoyama S; Konishi T; Kawahara M; Kaminishi M; Ito A; Hojo K; Takeda Y; Oba H; Shimizu S
    Jpn J Clin Oncol; 1999 Mar; 29(3):132-6. PubMed ID: 10225695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus.
    Salcedo J; Suen SC; Bian SX
    Cancer Med; 2020 Jan; 9(2):440-446. PubMed ID: 31749330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage endoscopic submucosal dissection for recurrent esophageal squamous-cell carcinoma after definitive chemoradiotherapy.
    Ishii N; Suzuki K; Fujita Y
    Clin J Gastroenterol; 2011 Apr; 4(2):85-8. PubMed ID: 26190711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal cancer diagnosed during pregnancy presenting a therapeutic dilemma: A case report.
    Samejima K; Nagai T; Kizaki Y; Shigematsu K; Kurose Y; Uotani T; Akahori T; Takai Y
    Gynecol Oncol Rep; 2021 Nov; 38():100879. PubMed ID: 34926760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma.
    Tsujinaka T; Shiozaki H; Yamamoto M; Inoue M; Yano M; Doki Y; Monden M
    Am J Surg; 1999 Jun; 177(6):503-6; discussion 507. PubMed ID: 10414703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.